GM-CSF DNA: An adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine
- 5 December 2007
- journal article
- Published by Elsevier BV in Virology
- Vol. 369 (1), 153-167
- https://doi.org/10.1016/j.virol.2007.07.017
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Monocytes give rise to mucosal, but not splenic, conventional dendritic cellsThe Journal of Experimental Medicine, 2006
- Projections of Global Mortality and Burden of Disease from 2002 to 2030PLoS Medicine, 2006
- Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 InfectionPLoS Medicine, 2006
- Generation of Gut-Homing IgA-Secreting B Cells by Intestinal Dendritic CellsScience, 2006
- DNA/MVA Vaccine for HIV Type 1: Effects of Codon-Optimization and the Expression of Aggregates or Virus-Like Particles on the Immunogenicity of the DNA PrimeAIDS Research and Human Retroviruses, 2004
- Detection of Mucosal Antibodies in HIV Type 1-Infected IndividualsAIDS Research and Human Retroviruses, 2002
- Protection of Rhesus Macaques against LethalPlasmodium knowlesiMalaria by a Heterologous DNA Priming and Poxvirus Boosting Immunization RegimenInfection and Immunity, 2002
- Retrospective Analysis of Viral Load and SIV Antibody Responses in Rhesus Macaques Infected with Pathogenic SIV: Predictive Value for Disease ProgressionAIDS Research and Human Retroviruses, 1999
- HIV-Specific Cellular and Humoral Immune Responses in Primary HIV InfectionAIDS Research and Human Retroviruses, 1996
- Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1992